共查询到20条相似文献,搜索用时 15 毫秒
1.
Pieters T Haenebalcke L Hochepied T D'Hont J Haigh JJ van Roy F van Hengel J 《Stem cell reviews》2012,8(3):768-778
Classic derivation of mouse embryonic stem (ES) cells from blastocysts is inefficient, strain-dependent, and requires expert skills. Over recent years, several major improvements have greatly increased the success rate for deriving mouse ES cell lines. The first improvement was the establishment of a user-friendly and reproducible medium-alternating protocol that allows isolation of ES cells from C57BL/6 transgenic mice with efficiencies of up to 75%. A recent report describes the use of this protocol in combination with leukemia inhibitory factor and pluripotin treatment, which made it possible to obtain ES cells from F1 strains with high efficiency. We report modifications of these protocols for user-friendly and reproducible derivation of mouse ES cells with efficiencies of up to 100%. Our protocol involves a long initial incubation of primary outgrowths from blastocysts with pluripotin, which results in the formation of large spherical outgrowths. These outgrowths are morphologically distinct from classical inner cell mass (ICM) outgrowths and can be easily picked and trypsinized. Pluripotin was omitted after the first trypsinization because we found that it blocks attachment of ES cells to the feeder layer and its removal facilitated formation of ES cell colonies. The newly established ES cells exhibited normal karyotypes and generated chimeras. In summary, our user-friendly modified protocol allows formation of large spherical ICM outgrowths in a robust and reliable manner. These outgrowths gave rise to ES cell lines with success rates of up to 100%. 相似文献
2.
Schwann cells (SC), the glial cells of peripheral nerves, are involved in many diseases including Charcot Marie Tooth and
neurofibromatosis, and play a pivotal role in peripheral nerve regeneration. Although it is possible to obtain human SC from
nerve biopsies, they are difficult to maintain and expand in culture. Here we describe an efficient system for directing the
differentiation of human embryonic stem cells (hESC) into cells with the morphological and molecular characteristics of SC.
Neurospheres were generated from hESC using stromal cell induction and grown under conditions supportive of SC differentiation.
After 8 weeks, hESC-derived SC expressed characteristic markers GFAP, S100, HNK1, P75, MBP and PMP-22, and were observed in
close association with hESC-derived neurites. ~60% of the cells were double-immunostained for the SC markers GFAP/S100. RT-PCR
analysis confirmed the expression of GFAP, S100, P75, PMP-22 and MBP and demonstrated expression of the SC markers P0, KROX20
and PLP in the cultures. Expression of CAD19 was observed in 2 and 4 week cultures and then was down-regulated, consistent
with its expression in SC precursor, but not mature stages. Co-culture of hESC-derived SC with rat, chick or hESC-derived
axons in compartmentalized microfluidic chambers resulted in tight association of the SC with axons. Apparent wrapping of
the axons by SC was occasionally observed, suggestive of myelination. Our method for generating SC from hESC makes available
a virtually unlimited source of human SC for studies of their role in nerve regeneration and modeling of disease. 相似文献
3.
4.
For the past 12 years, the biology and applications of human embryonic stem cells (hESCs) have received great attention from the scientific community. Derivatives of the first hESC line obtained by J. Thomson's group (Science 282(5391):1145-1147, 1998) have been used in clinical trials in patients with spinal cord injury, and other hESC lines have now been used to generate cells for use in treating blindness (Lancet 379(9817):713-720, 2012). In addition to the classical protocol based on mouse or human feeder layers using open culture methods (In Vitro Cellular & Developmental Biology - Animal 46(3-4):386-394, 2010; Stem Cells 23(9):1221-1227, 2005; Nature Biotechnology 24(2):185-187, 2006; Human Reproduction 21(2):503-511, 2006; Human Reproduction 20(8):2201-2206, 2005; Fertility and Sterility 83(5):1517-1529, 2005), novel hESC lines have been derived xeno-free (without using animal derived reagents) (PLoS One 5 (4):1024-1026, 2010), feeder-free (without supporting cell monolayers) (Lancet 365(9471):1601-1603, 2005), in microdrops under oil (In Vitro Cellular & Developmental Biology - Animal 46(3-4):236-41, 2010) and in suspension with ROCK inhibitor (Nature Biotechnology 28(4):361-4, 2010). Regardless of the culture system, successful hESC derivation usually requires optimization of embryo culture, the careful and timely isolation of its inner cell mass (ICM), and precise culture conditions up to the establishment of pluripotent cell growth during hESC line derivation. Herein we address the crucial steps of the hESC line derivation protocol, and provide tips to apply quality control to each step of the procedure. 相似文献
5.
Efforts to efficiently derive embryonic stem cells (ESC) from isolated blastomeres have been done to minimize ethical concerns
about human embryo destruction. Previous studies in our laboratory indicated a poor derivation efficiency of mouse ESC lines
from isolated blastomeres at the 8-cell stage (1/8 blastomeres) due, in part, to a low division rate of the single blastomeres
in comparison to their counterparts with a higher number of blastomeres (2/8, 3/8 and 4/8 blastomeres). Communication and
adhesion between blastomeres from which the derivation process begins could be important aspects to efficiently derive ESC
lines. In the present study, an approach consisting in the adhesion of a chimeric E-cadherin (E-cad-Fc) to the blastomere
surface was devised to recreate the signaling produced by native E-cadherin between neighboring blastomeres inside the embryo.
By this approach, the division rate of 1/8 blastomeres increased from 44.6% to 88.8% and a short exposure of 24 h to the E-cad-Fc
produced an ESC derivation efficiency of 33.6%, significantly higher than the 2.2% obtained from the control group without
E-cad-Fc. By contrast, a longer exposure to the same chimeric protein resulted in higher proportions of trophoblastic vesicles.
Thus, we establish an important role of E-cadherin-mediated adherens junctions in promoting both the division of single 1/8
blastomeres and the efficiency of the ESC derivation process. 相似文献
6.
Human embryonic stem cells (hESCs) are a potential source of material for cell therapy of muscle diseases. To date, it has proven difficult to generate skeletal muscle from hESCs in high yields and within a reasonable timeframe. Further, a hESC-derived Pax3/7-positive skeletal muscle progenitor population has not yet been described. Previous studies have shown that Pax3/7-positive progenitor cells can repopulate the satellite cell niche, indicating the importance of this population for therapy. We sought to optimize the differentiation of hESCs into skeletal muscle in order to characterize myogenesis at a molecular level and shorten the time course. We treated hESCs with retinoic acid (RA) and found an enhancement of skeletal myogenesis, and the expression of the myogenic regulatory factors (MRFs) MyoD and myogenin by day 25. Furthermore, we found that RA treatment expanded the muscle progenitor pool, which occurred as a distinct Pax3(+ve) population prior to MRF expression. Non-skeletal muscle tissue types were not significantly affected. Therefore, we have identified a differentiation pathway in hESCs that provides a skeletal muscle progenitor population which can undergo myogenesis more efficiently. We propose that RA could fit into a directed culture method for deriving skeletal muscle from hESCs. 相似文献
7.
8.
9.
人胚脑皮层神经干细胞的分离培养及鉴定 总被引:3,自引:2,他引:3
目的 从人胚脑皮层中分离培养并鉴定神经干细胞,方法 利用无血清培养和单细胞克隆技术在人胚脑皮层中分离出具有单细胞克隆能力的细胞,并进行培养、传代、分化观察,采用间接免疫荧光检测克隆细胞的神经巢蛋白(Nestin)抗原和分化后特异性成熟神经细胞抗原的表达。结果 从胚龄10周的新鲜人胚脑皮层中成功分离出神经干细胞,该细胞具有连续克隆能力,可传代培养,表达神经巢蛋白抗原,分化后的细胞表达神经元细胞,胶质细胞和少突胶质细胞的特异性抗原。结论 人胚脑皮层中存在具有自我更新能力和多分化潜能的神经干细胞。 相似文献
10.
Elaine Vo Donny Hanjaya-Putra Yuanting Zha Sravanti Kusuma Sharon Gerecht 《Stem cell reviews》2010,6(2):237-247
Engineering vascularized tissue is crucial for its successful implantation, survival, and integration with the host tissue.
Vascular smooth muscle cells (v-SMCs) provide physical support to the vasculature and aid in maintaining endothelial viability.
In this study, we show an efficient derivation of v-SMCs from human embryonic stem cells (hESCs), and demonstrate their functionality
and ability to support the vasculature in vitro. Human ESCs were differentiated in monolayers and supplemented with platelet-derived
growth factor-BB (PDGF-BB) and transforming growth factor-beta 1 (TGF-β1). Human ESC-derived smooth-muscle-like cells (SMLCs)
were found to highly express specific smooth muscle cell (SMC) markers—including α-smooth muscle actin, calponin, SM22, and
smooth muscle myosin heavy chain—to produce and secrete fibronectin and collagen, and to contract in response to carbachol.
In vitro tubulogenesis assays revealed that these hESC-derived SMLCs interacted with human endothelial progenitor cell (EPCs)
to form longer and thicker cord-like structures in vitro. We have demonstrated a simple protocol for the efficient derivation
of highly purified SMLCs from hESCs. These in vitro functional SMLCs interacted with EPCs to support and augment capillary-like
structures (CLSs), demonstrating the potential of hESCs as a cell source for therapeutic vascular tissue engineering. 相似文献
11.
Lina Sui Mieke Geens Karen Sermon Luc Bouwens Josué Kunjom Mfopou 《Stem cell reviews》2013,9(5):569-577
Transplantation of pancreatic progenitors derived from human embryonic stem cells (hESCs) is a promising way to treat diabetes. Strategies to obtain the required cell mass would rely on the up scaling of current differentiation protocols, or the proliferation of committed progenitors. We aimed at finding conditions that maintain a proliferating pancreatic progenitor pool and we assessed the role of BMP4 signaling in this process. hESCs were differentiated into PDX1 positive pancreatic progenitor stage following our established protocol with few modifications, and then the progenitor cells were passaged in a defined proliferation medium (PM). During passage, the effect of BMP4 signaling on the differentiation and proliferation of pancreatic progenitors was examined by RT-PCR and immunofluorescence analysis. We found that PDX1 positive pancreatic progenitors proliferated and gained NKX6.1 expression in the PM, whereas they failed to express NKX6.1 if BMP signaling was inhibited with Noggin. In this latter condition, part of the progenitors rather generated pro-endocrine cells denoted by NGN3 and synaptophysin expression. On the contrary, addition of BMP4 to the PM promoted the early derivation of PDX1 and NKX6.1 coexpressing pancreatic progenitors. Our findings are in line with mouse pancreas development, and indicate that BMP4 signaling is required for the derivation and maintenance of hESC-derived PDX1+NKX6.1+ pancreatic progenitors. These results are instructive for guiding the development of an efficient pancreas differentiation protocol in view of diabetes cell replacement therapy. 相似文献
12.
13.
Christoffer Tamm Sandeep Kadekar Sara Pijuan-Galitó Cecilia Annerén 《Stem cell reviews》2016,12(5):584-591
Reliable and efficient DNA and RNA transfection methods are required when studying the role of individual genes in mouse pluripotent stem cells. However, these cells usually grow in tight clusters and are therefore more difficult to transfect than many other cell lines. We have found that transfection is especially challenging when mouse embryonic stem (mES) cells are cultured in the newly described 2i medium, which is based on two chemical inhibitors of differentiation pathways. In the present study we have performed a side-by-side comparison of commercially available, non-viral transfection reagents with regard to their ability to deliver plasmid DNA and siRNA into adherent and/or trypsinized mES cells cultured in 2i medium, assessing transfection rates, plasmid gene expression, siRNA mediated knockdown of Oct4 and viability. Finally, we present a fast and efficient method for transfection of trypsinized mES cells using the liposomal-based Lipofectamine 2000. With only a five-minute long transfection time we obtained at least 85 % transfected cells with 80 % maintained viability. Moreover, this protocol saves up to a day of experimental time since the cells are in suspension at the time of transfection, which allows for immediately re-plating into the appropriate format. This fast, simplified and highly efficient transfection method will be valuable for both basic research and high-throughput applications. 相似文献
14.
Michal Amit Judith Chebath Victoria Margulets Ilana Laevsky Yael Miropolsky Kohava Shariki Meital Peri Idit Blais Guy Slutsky Michel Revel Joseph Itskovitz-Eldor 《Stem cell reviews》2010,6(2):248-259
Alongside their contribution to research, human embryonic stem cells (hESC) may also prove valuable for cell-based therapies. Traditionally, these cells have been grown in adhesion culture either with or without feeder cells, allowing for their continuous growth as undifferentiated cells. However, to be applicable in therapy and industry they must be produced in a scalable and controlled process. Here we present for the first time a suspension culture system for undifferentiated hESC and induced pluripotent stem cells (iPSC), based on medium supplemented with the IL6RIL6 chimera (interleukin-6 receptor fused to interleukin-6), and basic fibroblast growth factor. Four hESC lines cultured in this system maintained all ESC features after 20 passages, including stable karyotype and pluripotency. Similar results were obtained when hESC were replaced with iPSC from two different cell lines. We demonstrate that the IL6RIL6 chimera supports the self-renewal and expansion of undifferentiated hESC and iPSC in suspension, and thus present another efficient system for large-scale propagation of undifferentiated pluripotent cells for clinical and translational applications. 相似文献
15.
Orthotropic liver transplantation is the only established treatment for end-stage liver diseases. Utilization of hepatocyte
transplantation and bio-artificial liver devices as alternative therapeutic approaches requires an unlimited source of hepatocytes.
Stem cells, especially embryonic stem cells, possessing the ability to produce functional hepatocytes for clinical applications
and drug development, may provide the answer to this problem. New discoveries in the mechanisms of liver development and the
emergence of induced pluripotent stem cells in 2006 have provided novel insights into hepatocyte differentiation and the use
of stem cells for therapeutic applications. This review is aimed towards providing scientists and physicians with the latest
advancements in this rapidly progressing field. 相似文献
16.
SA Kalashnikova GA Kovnatskaya AI Shchyogolev 《Bulletin of experimental biology and medicine》2012,152(4):516-518
We developed a protocol of in vitro differentiation of human embryonic stem cells into three-dimensional structures histologically and molecularly similar to
the developing retina. 相似文献
17.
18.
Murdoch A Braude P Courtney A Brison D Hunt C Lawford-Davies J Moore H Stacey G Sethe S;Procurement Working Group of National Clinical hESC Forum;National Clinical hESC Forum 《Stem cell reviews》2012,8(1):91-99
The donation of human embryos for the derivation of embryonic stem cell lines that may be used in the development of therapeutic
products raises more complex ethical, practical and regulatory problems than the donation of embryos for non-clinical research.
This review considers these issues and offers recommendations for good practice. 相似文献
19.